Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Salmeterol MDI vs Diskus in Healthy Males
NCT02254226Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of salmeterol in asthma and chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity up to 6 hours and Maximum plasma concentration up to 6 hours. Started Nov 2004; status: completed.
02
Drugs
salmeterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02254226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254226.